These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Cytomegalovirus Triplex vaccine in pediatric hematopoietic stem cell transplant patients at high risk for cytomegalovirus complications: evaluation of vaccine safety, immunogenicity and impact on viremia requiring antivirals. La Rosa C; Park Y; Yang D; Zhou Q; Kaltcheva T; Karras N; Cheng J; Sun W; Diamond DJ; Pawlowska A Haematologica; 2024 Jul; 109(7):2303-2308. PubMed ID: 38426277 [No Abstract] [Full Text] [Related]
8. Kinetics of interferon-gamma producing cytomegalovirus (CMV)-specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantation. Eid AJ; Brown RA; Hogan WJ; Lahr BD; Eckel-Passow JE; Litzow MR; Razonable RR Transpl Infect Dis; 2009 Dec; 11(6):519-28. PubMed ID: 19744286 [TBL] [Abstract][Full Text] [Related]
9. Prevention of cytomegalovirus following solid organ transplantation: a literature review. Kowalsky S; Arnon R; Posada R Pediatr Transplant; 2013 Sep; 17(6):499-509. PubMed ID: 23890075 [TBL] [Abstract][Full Text] [Related]
13. Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients. Tormo N; Solano C; Benet I; Clari MA; Nieto J; de la Cámara R; López J; López-Aldeguer N; Hernández-Boluda JC; Remigia MJ; Garcia-Noblejas A; Gimeno C; Navarro D Bone Marrow Transplant; 2010 Mar; 45(3):543-9. PubMed ID: 19617905 [TBL] [Abstract][Full Text] [Related]
14. Unraveling the biologic basis of late-onset cytomegalovirus disease in high-risk organ transplant recipients. Singh N Transplantation; 2011 Apr; 91(8):825-6. PubMed ID: 21372754 [No Abstract] [Full Text] [Related]
15. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Kotton CN; Kumar D; Caliendo AM; Asberg A; Chou S; Snydman DR; Allen U; Humar A; Transplantation; 2010 Apr; 89(7):779-95. PubMed ID: 20224515 [TBL] [Abstract][Full Text] [Related]
16. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients. Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637 [TBL] [Abstract][Full Text] [Related]
17. Vaccination against the human cytomegalovirus. Plotkin SA; Boppana SB Vaccine; 2019 Nov; 37(50):7437-7442. PubMed ID: 29622379 [TBL] [Abstract][Full Text] [Related]